Health

Illumina has anchored the second fund to be closed by the venture firm it sponsors, with Ireland Strategic Investment Fund among the limited partners.

The cancer treatment developer is set to go public in an offering which would represent exits for Pfizer Ventures, Leaps by Bayer and Ipsen.

Arctos Medical, which is developing gene therapies to treat sight loss, had raised $8.1m from investors including Novartis two years ago.

University of Bern spinout Arctos Medical has been acquired by existing shareholder Novartis.

The Baidu Ventures-backed clinical research software provider received $23.2m in the round, which will fund further work on its core platform.

Oracle has signed up to be a cornerstone investor for Oxford Nanopore’s initial public offering, putting up half of the $410m target.

Ideo contributed to female-focused debit card provider Sequin's $5m seed round while Nikon has exited motion data software developer Wrnch.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

ProAssurances and Reylens Group helped the surgical software provider add $30m to a series C round now totalling $130m.

Swire Pacific led a funding round for the cardiovascular healthcare provider as it prepares to expand its network of facilities in China.

Hinge Health has bought Wrnch, a computer vision technology developer exploiting research from Concordia University.